Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?
Zaid Elsabbagh(Johns Hopkins University), Uma Srikumaran(Johns Hopkins University), Sudarsan Murali(Johns Hopkins University), Matthew J. Best(Johns Hopkins University), Edward G. McFarland(Johns Hopkins University), Mark Haft(Johns Hopkins University)
Cited by 24
Related Papers
Increasing incidence of primary reverse and anatomic total shoulder arthroplasty in the United States
|Journal of Shoulder and Elbow Surgery|2020|464
Management of irreparable massive rotator cuff tears: a systematic review and meta-analysis of patient-reported outcomes, reoperation rates, and treatment response
|Journal of Shoulder and Elbow Surgery|2020|212
Racial Disparities in the Use of Surgical Procedures in the US
|JAMA Surgery|2021|174
Reverse Total Shoulder Arthroplasty without Bone-Grafting for Severe Glenoid Bone Loss in Patients with Osteoarthritis and Intact Rotator Cuff
|Journal of Bone and Joint Surgery|2016|115
Patterns of Pediatric Supracondylar Humerus Fractures
|Journal of Pediatric Orthopaedics|2008|112